As of January 22, 2025, Cytosorbents (CTSO) has a market cap of $62.148 million USD. According to our data, Cytosorbents is ranked No.8025 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $62.15 M |
12.09%
|
Dec 31, 2024 | $55.45 M |
-18.02%
|
Dec 29, 2023 | $67.63 M |
-28.39%
|
Dec 30, 2022 | $94.44 M |
-63.01%
|
Dec 31, 2021 | $0.26 B |
-47.43%
|
Dec 31, 2020 | $0.49 B |
107.01%
|
Dec 31, 2019 | $0.23 B |
-52.35%
|
Dec 31, 2018 | $0.49 B |
24.31%
|
Dec 29, 2017 | $0.40 B |
19.27%
|
Dec 30, 2016 | $0.33 B |
-2.15%
|
Dec 31, 2015 | $0.34 B |
-44.02%
|
Dec 31, 2014 | $0.61 B |
218.40%
|
Dec 31, 2013 | $0.19 B |
-3.85%
|
Dec 31, 2012 | $0.20 B |
-18.75%
|
Dec 30, 2011 | $0.24 B |
14.29%
|
Dec 31, 2010 | $0.21 B |
-26.32%
|
Dec 31, 2009 | $0.29 B |
137.50%
|
Dec 31, 2008 | $0.12 B |
-63.64%
|
Dec 31, 2007 | $0.34 B |
-86.67%
|
Dec 29, 2006 | $2.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Baxter
BAX
|
$16.25 B |
-0.000 M
|
USA
|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
Medtronic
MDT
|
$112.64 B |
0.001 M
|
Ireland
|
Edwards Lifesciences
EW
|
$40.72 B |
0.002 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Boston Scientific
BSX
|
$147.84 B |
-0.008 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Stryker Corporation
SYK
|
$148.86 B |
-0.006 M
|
USA
|
Zimmer Biomet
ZBH
|
$21.84 B |
-0.000 M
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
3M
MMM
|
$80.45 B |
0.002 M
|
USA
|
Market Cap | = | CTSO Stock Price | * | CTSO Shares Outstanding |
= | $1.02 | * | 60.93 M | |
= | $62.15 M |